BioSpecifics sales and marketing update

BioSpecifics Technologies Corp. (BSTC) Sales of BSTC's Collagenase ABC, an enzyme-based product used to debride dermal ulcers and severe burns, rose to $1.2 million in the third quarter ended Oct. 31...